A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention
Joint Authors
Wu, Huan-Lin
Wang, Yun-Fei
Li, Jun-Zhe
Zhang, Min-Zhou
Sheng, Xiao-Gang
Wang, Xia
Li, Song
Chen, Qiu-Xiong
Li, Xiao-Qing
Ou, Ai-hua
Ruan, Xin-Min
Source
Evidence-Based Complementary and Alternative Medicine
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-05-26
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Percutaneous coronary intervention (PCI) is widely used in clinical treatment of coronary artery disease.
However, the effects of PCI on preventing restenosis after revascularization and improving the quality of life were not satisfying.
Huxin Formula is formulated by modifying an experienced Chinese medicine formula and has been widely used in clinical practice due to its marked effects on coronary heart disease.
A multicentre double-blind randomized controlled clinical trial was designed to evaluate the effects and safety of Huxin Formula in patients undergoing PCI.
Our results showed that there was no significant difference between the two groups in main outcomes.
For patients with ejection fraction (EF) > 50%, score of the quality of life scale was higher in treatment group compared with control group.
For patients with unstable angina, score of the quality of life scale in 360 days was significantly higher in treatment group compared with control group ( P < 0.05 ).
No obvious adverse reaction was found in the use of Huxin Formula.
In conclusion, Huxin Formula, believed to be a safe treatment for patients after PCI, has benefits in improving the quality of life in patients with unstable angina though it failed to show superiority in primary and secondary outcomes.
American Psychological Association (APA)
Wu, Huan-Lin& Wang, Yun-Fei& Li, Jun-Zhe& Zhang, Min-Zhou& Sheng, Xiao-Gang& Wang, Xia…[et al.]. 2014. A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention. Evidence-Based Complementary and Alternative Medicine،Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1018138
Modern Language Association (MLA)
Wu, Huan-Lin…[et al.]. A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention. Evidence-Based Complementary and Alternative Medicine No. 2014 (2014), pp.1-7.
https://search.emarefa.net/detail/BIM-1018138
American Medical Association (AMA)
Wu, Huan-Lin& Wang, Yun-Fei& Li, Jun-Zhe& Zhang, Min-Zhou& Sheng, Xiao-Gang& Wang, Xia…[et al.]. A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention. Evidence-Based Complementary and Alternative Medicine. 2014. Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1018138
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1018138